Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
8/05 | 2,950 USD
-1,01% |
-1,01% |
|
Cabaletta Bio Inc |
8/05 | 3,880 USD
-3,00% |
-3,00% |
|
Calithera Biosciences Inc |
8/05 | 0,000 USD
0,00% |
0,00% |
Cambridge Cognition Holdings plc |
8/05 | 35,000 GBX
0,00% |
0,00% |
|
Can-Fite Biopharma Ltd |
8/05 | 3,510 USD
-0,85% |
-0,85% |
|
Capricor Therapeutics Inc |
8/05 | 30,380 USD
-10,49% |
-10,49% |
Carbios |
8/05 | 7,550 EUR
-1,44% |
-1,44% |
Cardiol Therapeutics Inc - Class A |
8/05 | 1,800 CAD
+1,12% |
+1,12% |
|
Caredx Inc |
8/05 | 21,820 USD
+1,77% |
+1,77% |
|
Carisma Therapeutics, Inc. |
8/05 | 0,001 USD
0,00% |
0,00% |
|
Cassava Sciences Inc |
8/05 | 1,300 USD
-4,41% |
-4,41% |
|
Castle Biosciences Inc |
8/05 | 19,830 USD
+3,07% |
+3,07% |
|
Catalyst Pharmaceuticals Inc |
8/05 | 31,150 USD
-0,05% |
-0,05% |
|
Cel-Sci Corp. |
8/05 | 1,700 USD
+6,25% |
+6,25% |
|
Celldex Therapeutics Inc. |
8/05 | 33,970 USD
+1,95% |
+1,95% |
|
Cellectar Biosciences Inc |
8/05 | 3,100 USD
-6,06% |
-6,06% |
|
Cellectis |
8/05 | 3,198 EUR
-1,72% |
-1,72% |
|
Cellectis |
8/05 | 3,850 USD
-0,26% |
-0,26% |
Celyad Oncology |
8/05 | 0,302 EUR
-4,13% |
-4,13% |
|
Cerus Corp. |
8/05 | 2,610 USD
0,00% |
0,00% |
|
Champions Oncology Inc |
8/05 | 6,020 USD
+0,50% |
+0,50% |
|
Charlottes Web Holdings Inc |
8/05 | 0,620 CAD
0,00% |
0,00% |
|
China Pharma Holdings Inc. |
8/05 | 0,530 USD
+0,74% |
+0,74% |
|
China SXT Pharmaceuticals Inc |
8/05 | 1,730 USD
+4,22% |
+4,22% |
|
Cipher Pharmaceuticals Inc |
8/05 | 19,740 CAD
+10,46% |
+10,46% |
|
Citius Pharmaceuticals Inc |
8/05 | 0,640 USD
-2,16% |
-2,16% |
|
Clean Air Metals Inc |
8/05 | 0,065 CAD
+8,33% |
+8,33% |
|
ClearPoint Neuro Inc |
8/05 | 12,820 USD
+9,76% |
+9,76% |
|
Clearside Biomedical Inc |
8/05 | 0,310 USD
0,00% |
0,00% |
|
Cns Pharmaceuticals Inc |
8/05 | 7,290 USD
+2,68% |
+2,68% |
|
Co-Diagnostics Inc |
8/05 | 2,530 USD
+31,09% |
+31,09% |
|
Cocrystal Pharma Inc |
8/05 | 1,440 USD
+3,60% |
+3,60% |
|
Cogent Biosciences Inc |
8/05 | 34,740 USD
-0,14% |
-0,14% |
|
Coherus Biosciences Inc |
8/05 | 1,750 USD
-0,57% |
-0,57% |
|
Collegium Pharmaceutical Inc |
8/05 | 37,800 USD
-3,89% |
-3,89% |
|
CollPlant Biotechnologies Ltd |
8/05 | 0,402 USD
+2,37% |
+2,37% |
Coloplast |
8/05 | 54,440 EUR
+0,15% |
+0,15% |
|
Compass Pathways Plc |
8/05 | 9,910 USD
+5,54% |
+5,54% |
|
Compass Therapeutics Inc |
8/05 | 1,830 USD
+1,10% |
+1,10% |
|
Compugen Ltd. |
8/05 | 2,900 USD
+1,40% |
+1,40% |
|
Conmed Corp. |
8/05 | 36,760 USD
-3,52% |
-3,52% |
|
Convatec Group |
8/05 | 205,200 GBX
-1,82% |
-1,82% |
|
Cooper Companies, Inc. |
8/05 | 60,000 USD
-1,82% |
-1,82% |
|
Corbus Pharmaceuticals Holdings Inc |
8/05 | 10,960 USD
+0,83% |
+0,83% |
|
Corcept Therapeutics Inc |
8/05 | 52,280 USD
+2,41% |
+2,41% |
|
CorMedix Inc |
8/05 | 7,920 USD
0,00% |
0,00% |
|
Corvus Pharmaceuticals Inc |
8/05 | 15,550 USD
+6,58% |
+6,58% |
|
Covalon Technologies Ltd. |
8/05 | 1,950 CAD
+1,04% |
+1,04% |
|
Creo Medical Group Plc |
8/05 | 12,625 GBX
-0,98% |
-0,98% |
|
Crescita Therapeutics Inc |
7/05 | 0,760 CAD
0,00% |
0,00% |
|
Crinetics Pharmaceuticals Inc |
8/05 | 37,480 USD
-13,82% |
-13,82% |
|
CRISPR Therapeutics AG |
8/05 | 54,830 USD
+4,60% |
+4,60% |
|
Cronos Group Inc |
8/05 | 2,540 USD
-1,17% |
-1,17% |
|
Crossject |
8/05 | 1,910 EUR
-6,37% |
-6,37% |
|
Cryo-Cell International, Inc. |
8/05 | 3,453 USD
-3,54% |
-3,54% |
|
Cue Biopharma Inc |
8/05 | 35,000 USD
-2,04% |
-2,04% |
|
Cumberland Pharmaceuticals Inc. |
8/05 | 4,680 USD
+9,09% |
+9,09% |
|
CureVac N.V. |
5/01 | 3,892 EUR
+0,36% |
+0,36% |
|
Curis Inc |
8/05 | 0,561 USD
-2,77% |
-2,77% |
|
Currenc Group Inc. |
8/05 | 4,470 USD
+3,71% |
+3,71% |
|
Cyanotech Corp. |
28/04 | 0,389 USD
0,00% |
0,00% |
|
Cyclerion Therapeutics Inc |
8/05 | 3,100 USD
-1,59% |
-1,59% |
|
Cytokinetics Inc |
8/05 | 76,910 USD
+3,53% |
+3,53% |
|
CytomX Therapeutics Inc |
8/05 | 3,980 USD
-0,50% |
-0,50% |
|
Cytosorbents Corp |
8/05 | 0,609 USD
-0,08% |
-0,08% |